Search by Drug Name or NDC
NDC 50090-3178-04 Ondansetron Hydrochloride 4 mg/1 Details
Ondansetron Hydrochloride 4 mg/1
Ondansetron Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is ONDANSETRON HYDROCHLORIDE.
MedlinePlus Drug Summary
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 50090-3178-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ondansetron
Product Information
NDC | 50090-3178 |
---|---|
Product ID | 50090-3178_f74fee7b-ae98-4fbb-84fb-23cd573e3936 |
Associated GPIs | 50250065050310 |
GCN Sequence Number | 016392 |
GCN Sequence Number Description | ondansetron HCl TABLET 4 MG ORAL |
HIC3 | H6J |
HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
GCN | 20041 |
HICL Sequence Number | 006055 |
HICL Sequence Number Description | ONDANSETRON HCL |
Brand/Generic | Generic |
Proprietary Name | Ondansetron Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ondansetron Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 4 |
Active Ingredient Units | mg/1 |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Labeler Name | A-S Medication Solutions |
Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078539 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50090-3178-04 (50090317804)
NDC Package Code | 50090-3178-4 |
---|---|
Billing NDC | 50090317804 |
Package | 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3178-4) |
Marketing Start Date | 2014-11-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |